Deerfield Management has added yet another commercialisation fund to its roster, this time partnering University of Illinois at Chicago for a $65m vehicle.

Siemens is set to exit the app orchestration software provider in an acquisition of undisclosed size by CloudBees, having invested in the company in 2014.

SparkLabs Frontier-ASU will be open to student and alumni-led startups, providing an initial cohort of six-to-eight with training, mentoring and opportunities to secure funding.

MSU’s Student Venture Capital Fund will invest up to $50,000 in university-linked businesses with the administrative aid of MSU students taking the entrepreneurial finance course.

Applied Morphomics has formally spun out of University of Michigan to deliver a medical analytics service powered by morphological scans of patients.

Toyota, SoftBank and Denso have confirmed they have agreed to invest $1bn in Uber's autonomous driving spinoff at a $7.25bn post-money valuation.

The gene therapy developer's latest round featured a $75m investment from Novartis and was closed as it withdrew its IPO application.

Talaris, previously known as Regenerex and based on research at University of Louisville, will use the funding to advance its cell therapy into later-stage clinical development.

Gilead Sciences, Boehringer Ingelheim and Takeda all recorded exits as immunotherapy developer Hookipa went public, floating at the bottom of its range.

Life360, backed by ADT, BMW and Duchossois Group, plans to go public in Australia next month after pricing its shares for a company valuation of $494m.